News

CBB Member Marianna Foldvari, Pharmacy, is focusing on non-invasive gene therapy and drug delivery, using nanotechnology to treat and cure neurodegenerative diseases such as glaucoma.

“A focus right now is to develop nano-sized transporters that can reach the back of the eye to improve vision, especially in the treatment of glaucoma,” Foldvari says.

This year, the Centre for Bioengineering and Biotechnology launched its first ever Seed Fund program in hopes of driving scientific innovation, growth, and opportunity through the support of collaborative research across UW faculties.

Centre for Bioengineering and Biotechnology Seed Grant 2018 Recipients, along with their proposal title, are listed below.

CBB Member Zoya Leonenko, Biology, and Physics and Astronomy, is looking to support drug development that blocks toxic plaques found in the brains of people with Alzheimer's disease.

Leonenko says that a lack of understanding of Alzheimer's at the molecular level is one of the biggest obstacles to finding a cure. To address this, she is using advanced biphysics and nanotechnology methods in hopes of developing preventive strategies using molecules that work at the single molecular level. 

Jason Hrera, head of product, behavioural sciences at Walmart, speaks at the Persuasive Technology Conference at the University of Waterloo on Wednesday. - David Bebee , Waterloo Region Record

CBB Researcher Emmanuel Ho, Pharmacy, is developing a new tool to protect women from HIV infection.

CBB Member Susan Horton, School of Public Health and Health Systems, is part of an international team examining medical testing in resource-limited countries.

Congratulations to CBB Member Dr. Ning Jiang, System Design Engineering, for receiving an Early Researcher Award for his work on brain-computer interfacing: Where artificial intelligence meets human intelligence. The announcement is part of a larger investment by the Government of Ontario aimed at supporting research and innovative discoveries across Ontario.

CBB Member David Simakov, Chemical Engineering, discovers that farm manure holds the possibility of acting as a source of renewable energy to help reduce greenhouse gas emissions.

CBB Member Emmanuel Ho and collaborators from the University of Manitoba have created a new therapy to combat deadly bacteria infecting hospital patients worldwide.

The new therapy is a biocide able to target antibiotic-defiant bacteria such as Methicillin resistant Staphylococcus aureus (MRSA). The team's goal was to find a way around the superbug's defences, using a new approach based on material science.

Karly Smith, 3A biomedical engineering studen at UW and student of CBB member George Shaker, has qualified to the Top 75 in Canada for NSERC's Science, Action! Competition.